Skip to main content
BEAT
NASDAQ Life Sciences

HeartBeam与Mount Sinai合作,加速AI-ECG开发

feedReported by FinanceWire
Sentiment info
Positive
Importance info
7
Price
$1.186
Mkt Cap
$48.743M
52W Low
$0.54
52W High
$4
Market data snapshot near publication time

summarizeSummary

HeartBeam宣布与Mount Sinai建立战略合作伙伴关系,共同开发和验证下一代AI基于ECG算法,用于健康和临床应用,包括心脏病发作风险评估。这一合作对于HeartBeam来说是一个重要的运营发展,尤其是在其最近的10-K提交中强调了对其继续经营的重大疑虑。与Mount Sinai这样的著名机构的合作伙伴关系为HeartBeam的技术和战略方向提供了至关重要的验证,可能会提高其信誉并加速其产品管道的发展。投资者将密切关注这一合作的进展,作为解决公司财务挑战和驱动未来增长的潜在催化剂。

在该公告发布时,BEAT的交易价格为$1.19,交易所为NASDAQ,所属行业为Life Sciences,市值约为$4874.3万。 52周交易区间为$0.54至$4.00。 这则新闻被评估为积极市场情绪,重要性评分为7/10。 来源:FinanceWire。


show_chartPrice Chart

Share this article

Copied!

feed BEAT - Latest Insights

BEAT
Apr 16, 2026, 8:48 PM EDT
Filing Type: 4
Importance Score:
7
BEAT
Apr 16, 2026, 8:47 PM EDT
Filing Type: 4
Importance Score:
7
BEAT
Apr 16, 2026, 8:46 PM EDT
Filing Type: 4
Importance Score:
9
BEAT
Apr 16, 2026, 4:48 PM EDT
Filing Type: 8-K
Importance Score:
8
BEAT
Apr 15, 2026, 9:55 PM EDT
Filing Type: 424B5
Importance Score:
9
BEAT
Apr 14, 2026, 10:11 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
BEAT
Apr 14, 2026, 4:22 PM EDT
Filing Type: 424B5
Importance Score:
8
BEAT
Apr 14, 2026, 4:10 PM EDT
Source: Reuters
Importance Score:
8
BEAT
Mar 25, 2026, 12:46 PM EDT
Source: FinanceWire
Importance Score:
7
BEAT
Mar 13, 2026, 12:41 PM EDT
Source: FinanceWire
Importance Score:
7